Search

Your search keyword '"Kawaoka, Yoshihiro"' showing total 2,820 results

Search Constraints

Start Over You searched for: "Kawaoka, Yoshihiro" Remove constraint "Kawaoka, Yoshihiro"
2,820 results on '"Kawaoka, Yoshihiro"'

Search Results

1. Pathogenicity and transmissibility of bovine H5N1 influenza virus

4. A compendium of multi-omics data illuminating host responses to lethal human virus infections

11. Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial

13. Host range, transmissibility and antigenicity of a pangolin coronavirus

17. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

18. Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2

20. Defining the risk of SARS-CoV-2 variants on immune protection

21. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization.

24. Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage

27. Hypergraph Models of Biological Networks to Identify Genes Critical to Pathogenic Viral Response

30. Isolation of Bat Sarbecoviruses, Japan

31. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

32. Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination

34. Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents

35. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022

37. High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19

38. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections

42. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

43. Characterization of a new SARS-CoV-2 variant that emerged in Brazil

44. Quote of the Day

45. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

49. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

Catalog

Books, media, physical & digital resources